Lexicon Pharmaceuticals
LXRX
#6754
Rank
โ‚น75.77 B
Marketcap
โ‚น170.30
Share price
0.57%
Change (1 day)
26.20%
Change (1 year)

Lexicon Pharmaceuticals (LXRX) - Total liabilities

Total liabilities on the balance sheet as of June 2026 : โ‚น7.30 Billion

According to Lexicon Pharmaceuticals 's latest financial reports the company's total liabilities are โ‚น7.30 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Lexicon Pharmaceuticals - Total liabilities on balance sheet (from 2001 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31โ‚น6.95 B-46.85%
2024-12-31โ‚น13.07 B15.26%
2023-12-31โ‚น11.34 B77.7%
2022-12-31โ‚น6.38 B268.02%
2021-12-31โ‚น1.73 B-49.96%
2020-12-31โ‚น3.46 B-83.82%
2019-12-31โ‚น21.43 B-1.27%
2018-12-31โ‚น21.71 B-7.66%
2017-12-31โ‚น23.51 B8.74%
2016-12-31โ‚น21.62 B-11.12%
2015-12-31โ‚น24.32 B104.89%
2014-12-31โ‚น11.87 B84.82%
2013-12-31โ‚น6.42 B11.65%
2012-12-31โ‚น5.75 B-18.17%
2011-12-31โ‚น7.03 B30.94%
2010-12-31โ‚น5.37 B22.8%
2009-12-31โ‚น4.37 B38.55%
2008-12-31โ‚น3.15 B-2.76%
2007-12-31โ‚น3.24 B-30.03%
2006-12-31โ‚น4.64 B-22.42%
2005-12-31โ‚น5.98 B52.79%
2004-12-31โ‚น3.91 B-27.13%
2003-12-31โ‚น5.37 B251.48%
2002-12-31โ‚น1.52 B46.52%
2001-12-31โ‚น1.04 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Thermo Fisher Scientific
TMO
โ‚น5.841 T 79,817.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
โ‚น375.71 B 5,040.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
โ‚น969.45 B 13,164.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
โ‚น149.78 B 1,949.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
โ‚น117.88 B 1,512.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
โ‚น74.54 B 920.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
โ‚น52.20 B 614.33%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚น522.67 B 7,051.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
โ‚น0.30 B-95.88%๐Ÿ‡บ๐Ÿ‡ธ USA